WC
GBIM

Wexford Capital’s GLOBEIMMUNE INC COM STK (DE) GBIM Stock Holding History

Wexford Capital’s Portfolio GBIM Stock Details GBIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-264,644
Closed -$1.94M – 87
2015
Q1 		$1.94M Hold
264,644
– – 0.57% 30
2014
Q4 		$2.01M Hold
264,644
– – 0.39% 25
2014
Q3 		$1.83M Buy
+264,644
New +$2.71M 0.17% 64

Other funds holding GBIM

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wexford Capital's GBIM Position: Q2 2015 in Review

Wexford Capital sold out of GLOBEIMMUNE INC COM STK (DE) (GBIM) in Q2 2015, closing a stake of 264,644 shares — an estimated $1.94M sold.

Wexford Capital first reported a position in GBIM in Q3 2014 and held it in 3 quarters. The position peaked at $2.01M in Q4 2014. 9 funds tracked by Wall St. Rank hold GBIM as of Q2 2015.

  • Wexford Capital reported no remaining GLOBEIMMUNE INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Wexford Capital sold 264,644 GLOBEIMMUNE INC COM STK (DE) shares in Q2 2015, an estimated $1.94M.
  • Wexford Capital first reported a position in GLOBEIMMUNE INC COM STK (DE) in Q3 2014 and held it in 3 quarters.
  • Wexford Capital's GLOBEIMMUNE INC COM STK (DE) position peaked at $2.01M in Q4 2014.
  • 9 funds tracked by Wall St. Rank held GLOBEIMMUNE INC COM STK (DE) as of Q2 2015.

Based on Wexford Capital's 13F filing for Q2 2015, filed 12 Aug 2015.